Detalhe da pesquisa
1.
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
J Hepatol
; 80(1): 20-30, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734683
2.
An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysis.
J Viral Hepat
; 31(6): 324-341, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619214
3.
Estimating the prevalence of hepatitis delta virus infection among adults in the United States: A meta-analysis.
Liver Int
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563728
4.
Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.
Liver Int
; 44(1): 139-147, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787009
5.
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
J Hepatol
; 79(2): 576-580, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030400
6.
Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta.
J Viral Hepat
; 30(5): 406-416, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651603
7.
A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis.
Hepatology
; 75(6): 1551-1565, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34860418
8.
Treatment endpoints for chronic hepatitis D.
Liver Int
; 43 Suppl 1: 60-68, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36196680
9.
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial.
Liver Int
; 43(8): 1663-1676, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183524
10.
Emerging drugs for hepatitis D.
Expert Opin Emerg Drugs
; 28(2): 55-66, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096555
11.
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction.
J Viral Hepat
; 28(2): 410-419, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185325
12.
Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study.
Liver Int
; 41(2): 295-299, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217778
13.
WGO Guidance for the Care of Patients With COVID-19 and Liver Disease.
J Clin Gastroenterol
; 55(1): 1-11, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230011
14.
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.
J Hepatol
; 72(6): 1088-1096, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31981727
15.
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B.
J Hepatol
; 73(5): 1037-1045, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32553667
16.
Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta.
J Viral Hepat
; 27(12): 1359-1368, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32707605
17.
Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease.
Hepatology
; 69(4): 1464-1476, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30232804
18.
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy.
J Hepatol
; 70(5): 1008-1015, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982526
19.
New treatment options for delta virus: Is a cure in sight?
J Viral Hepat
; 26(6): 618-626, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30771261
20.
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study.
Hepatology
; 67(4): 1224-1236, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29152762